Lori Macomber insider trades: Karyopharm Therapeutics (KPTI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lori reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | KPTI | ↓ Sell | 1,626 | $6.30 | $10K | Direct | Feb 4, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KPTI insiders
Open-market trades in the last 12 months
About Lori Macomber's insider trades
Lori Macomber is EVP, CFO & Treasurer at Karyopharm Therapeutics (KPTI). Since Feb 3, 2026, Lori has reported no open-market purchases and 1 sale worth $10K on SEC Form 4. In the last 12 months: 1 sale ($10K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KPTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.